We reviewed the concordance between the clinical stage and pathologic stage for primary lung cancer. We evaluated 289 surgically resected lung cancers £ 3 cm. Multivariate survival analysis showed that the significant predictive factors for postoperative disease-free survival were pathologic stage and the maximum standardized uptake value (SUVmax) of primary lesions. Combining SUVmax with clinical stage might improve the prediction of therapeutic outcomes. Introduction: We aimed to determine the concordance between the clinical stage (c-stage) and pathologic stage (p-stage) for patients with small-size lung cancer. Additionally we searched for prognostic factors other than the TNM stage. Patients and Methods: We retrospectively reviewed the preoperative multidetector computed tomography (CT) and positron emission tomography/CT reports, surgical records, and pathologic reports of patients with primary lung cancer 3 cm. The Union for International Cancer Control TNM seventh edition classification of c-stage and p-stage were compared. The tumors were classified into multiple subgroups by concordance or discordance between the c-stage and p-stage. Disease-free survival (DFS) was assessed using survival analysis to assess the tumor characteristics that were predictive of prognosis. Results: A total of 289 surgically resected primary lung cancers were evaluated. The concordance between c-stage and p-stage was 65.4%, with moderate reproducibility (kappa coefficient, 0.467). The upstaging rate from c-stage I to p-stage II-IV was 9.4%, and these patients had significantly worse DFS than those with a concordant stage I classification (P < .001). The main reason for upstaging was an underestimation of metastases to the hilar lymph nodes (n ¼ 7) or mediastinal lymph nodes (n ¼ 11). A multivariate Cox proportional hazards model showed that the significant predictive factors for DFS were p-stage (hazard ratio, 1.342; P ¼ .003) and maximum standardized uptake value on positron emission tomography/CT (hazard ratio, 12.162; P ¼ .001). Conclusion: The concordance rate between c-stage and p-stage for small primary lung cancers had moderate reproducibility. Discordance between c-stage I and p-stage II-IV significantly affected DFS. The maximum standardized uptake value of the primary lesion was an independent prognostic factor, and combining it with c-stage might improve the prediction of therapeutic outcomes.
Introduction
The TNM staging of primary lung cancer has an important role in the therapeutic strategy decisions because it correlates with prognosis. TNM staging can be clinical (c-stage) and/or pathologic (p-stage), and the latter is used only for patients who have undergone surgical treatment. The c-stage is used for nonsurgical patients who have received chemotherapy and/or radiotherapy. A good correlation between the c-stage and p-stage is crucial; otherwise, treatment outcomes would be difficult to compare. Surgery is currently the standard treatment for small (maximum diameter, 3 cm) lung tumors; however, stereotactic radiotherapy (SRT) has been recently shown to have outcomes comparable with surgery. [1] [2] [3] [4] High-speed, multidetector computed tomography (MDCT) enables evaluation of the entire lungs and mediastinum. Using thinsection ( 1 mm) images, the size of the tumors and lymph nodes can be accurately measured. In addition, fluorine-18 fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) enables evaluation of the glucose metabolism of tumors and lymph nodes. Many studies have indicated that FDG-PET/CT is useful for determining the c-stage and therapeutic strategy for small-size lung cancer. [4] [5] [6] [7] [8] However, a recent study in the Netherlands reported that the accuracy of the c-stage for non-small-cell lung cancer (NSCLC) was low, even in the era of FDG-PET/CT. 9, 10 Few studies have investigated whether the PET/CT findings can salvage the discordance between the clinical and pathologic TNM staging.
In the present study, we focused on small-size primary lung cancer, which is often treatable by both surgery and SRT. The concordance rate between the c-stage and p-stage was investigated retrospectively and the effect of discordance on prognosis reviewed. Furthermore, we searched for prognostic factors other than the TNM stage.
Patients and Methods
The institutional review board of Nagoya University Hospital approved the present retrospective study (approval no. 2016-0270) and waived the requirement for written informed consent from the enrolled patients.
Patient Selection
Using the retrieval function of the picture archiving and communication system, we searched our institutional database for the CT, PET/CT, and pathologic reports on patients with pathologically confirmed, surgically resected primary lung cancer from August 2010 to December 2013. During the study period, 596 surgeries for lung cancer were performed in our institution. First, we selected patients who had undergone contrast-enhanced dynamic CT for preoperative evaluation of primary lung cancer within 3 months before treatment. Next, we selected primary tumors measuring 30 mm in the maximum diameter according to the preoperative CT or postoperative pathology reports.
The clinical records of all selected cases were reviewed to obtain data on patient age, sex, date of surgery, operative procedure, and postoperative course. Lobectomy and pneumonectomy were regarded as standard procedures, and wide wedge resection and segmentectomy were regarded as limited surgery. The patients were scheduled for follow-up chest radiographs and blood tests every 1 to 3 months for 2 years after surgery and every 6 months thereafter. CT of the chest and abdomen was performed every 6 to 12 months according to the physician's recommendations for ! 5 years. When recurrence was suspected, additional PET/CT imaging studies, transbronchial biopsy, or CT-guided needle biopsy were performed.
The radiologic information obtained from the thin-section CT reports included the date of examination, clinical tumor size (c-size), ratio of consolidation to tumor (C/T ratio) using the maximum diameter, tumor location, pleural invasion, and c-stage. The PET/ CT date and maximum standardized uptake value (SUVmax) of the primary tumor were also obtained. Extensive contact between a solid tumor and pleura and/or the presence of severe pleural indentations were considered to indicate pleural invasion. The pathologic information included tumor size (p-size), histologic type, pleural invasion, and p-stage.
In the present study, all c-stages and p-stages described on the radiologic and pathology reports were based on the seventh TNM classification of the Union for International Cancer Control. Tumors that did not have information about the c-stage were excluded from our cohort. Solid nodules were defined as those with a C/T ratio of 100%, and ground-glass nodules (GGNs) were defined as those with a C/T ratio of < 100%.
Contrast-enhanced MDCT Scanning Protocol
All CT scans were performed with a single-source MDCT scanner (Aquilion 64; Toshiba Medical, Tokyo, Japan). After noncontrast-enhanced CT, dual-phase (early phase and delayed phase) dynamic CT scans were performed. A total of 96 mL of nonionic contrast medium was used at a flow rate of 3.0 mL/s. The scan delay was 25 seconds after the start of contrast medium injection for the early phase and 90 seconds after for the delayed phase. The noncontrast-enhanced CT data were reconstructed with a slice thickness of 0.5 mm at 0.5-mm increments using a highspatial frequency algorithm and lung window settings (window level, À600 Hounsfield units [HU] ; window width, 1800 HU). Data from both early-and delayed-phase contrast CT scans were reconstructed with a slice thickness of 1.0 mm at 0.8-mm increments using standard algorithm and mediastinal window settings (window level, 40 HU; window width, 350 HU).
PET/CT Scan Protocol
Patients underwent PET/CT (Biograph 16 scanner; Siemens Healthcare, Tokyo, Japan) after !6 hours of fasting. The body area between the proximal femur and the base of the skull was scanned 1 hour after injection. The region of interest was defined as the surrounding primary lung lesions, regardless of the presence of solid nodules or GGNs, and the maximum value of a region of interest was defined as the SUVmax. PET or PET/CT scans obtained from other institution were assessed visually to diagnose lymph node metastasis and distant metastasis but were not used in the analysis of the primary lesion SUVmax.
Statistical Analysis
First, the correspondence rate between the c-stage and p-stage was analyzed using kappa coefficient (k). For solid nodules and GGNs, c-size and p-size were compared using Student's t test. Next, the tumors were classified into multiple subgroups according to the concordance or discordance between the c-stage and p-stage. Disease-free survival (DFS) was assessed using the Kaplan-Meier method, and the survival curves for each subgroup were compared using the log-rank test. DFS was defined as the interval between surgery and first disease recurrence, including locoregional recurrence and distant metastasis, or death from any cause. In patients with multiple synchronous lung cancers, the tumor with the highest p-stage was deemed to have relapsed. On univariate and multivariate analysis of DFS, a Cox proportional hazards model was used to assess the effects of tumor characteristics as potential prognostic e38 -Clinical Lung Cancer January 2018 FDG PET/CT and Staging of Lung Cancer factors. Finally, the tumors were classified into 3 subgroups using the combination of c-stage and SUVmax (c-stage I with SUVmax < 2.5, c-stage I with SUVmax ! 2.5, and c-stage II-IV). DFS was assessed using the Kaplan-Meier method, and the survival curves for each subgroup were compared using the log-rank test.
Analyses were performed using the commercial software SPSS, version 23 (IBM Corp., Armonk, NY), Excel 2013 (Microsoft Corp., Redmond, WA), and an add-in statistical software program (BellCurve, version 2.02; Social Survey Research Information Corp., Tokyo, Japan). A P < .05 was considered statistically significant.
Results
A total of 289 primary lung cancers in 270 patients were included in the present study ( Table 1 .
The correlation between c-stage and p-stage is presented in Table 2 . The concordance rate was 65.4%, with moderate reproducibility (k ¼ 0.467; P < .001). For the 240 tumors with both c-stage I and p-stage I data available, the concordance rate was 73.8%, with poor reproducibility (k ¼ 0.361; P < .001). The reason for upstaging from c-stage IA to p-stage IB (c-stage IA/p-stage IB) was an underestimation of the c-size (n ¼ 4), pleural invasion (n ¼ 18), and both c-size and pleural invasion (n ¼ 2). The reason for downstaging from c-stage IB to p-stage IA (c-stage IB/p-stage IA) was an overestimation of the c-size (n ¼ 10), pleural invasion (n ¼ 24), both c-size and pleural invasion (n ¼ 3), and atelectasis (n ¼ 1).
The upstaging rate from c-stage I to p-stage II-IV (c-stage I/p-stage II-IV) was 9.4% (25 of 265 tumors). The reason for upstaging was underestimation of metastases to the hilar lymph nodes (n ¼ 7) or mediastinal lymph nodes (n ¼ 11), chest wall invasion (n ¼ 4), a separate tumor nodule in the same lobe as the primary (n ¼ 1), and pleural dissemination (n ¼ 2). The reason for downstaging from c-stage II to III to p-stage I (c-stage II-III/p-stage I) was overestimation of metastases to the hilar lymph node (n ¼ 7) or mediastinal lymph nodes (n ¼ 1), chest wall invasion (n ¼ 1), and a separate tumor nodule in the same lobe as the primary (n ¼ 1).
Postoperative recurrence was observed in 34 patients with 34 tumors. Death from intercurrent disease or unexplained death was observed in 6 patients with 7 tumors. The DFS curves according to c-stage I and p-stage I (n ¼ 240) are shown in Figure 2 . No significant differences were found between c-stage IA/p-stage IA The results of univariate and multivariate analysis with the Cox proportional hazards model for DFS are presented in Table 3 . On univariate analysis, a solid nodule, SUVmax, histopathologic type, c-size, p-size, clinical pleural invasion, pathologic pleural invasion, c-stage, p-stage, and upstaging from c-stage to p-stage were significant factors correlating with the postoperative prognosis. On multivariate analysis, the postoperative prognosis correlated significantly with the SUVmax (P ¼ .001) and p-stage (P ¼ .003).
The DFS curves of the combination of c-stage I-IV and SUVmax (n ¼ 232) are shown in Figure 4 . In this analysis, the c-stage I tumors were classified into 2 subgroups using a cutoff value of SUVmax 2.5. Compared with c-stage I with an SUVmax of < 2.5 (n ¼ 105), the prognosis was significantly worse for c-stage I with an SUVmax of ! 2.5 (n ¼ 103; P < .001). In contrast, no significant differences were found between c-stage I with an SUVmax of ! 2.5 and c-stage II-IV (n ¼ 24; P ¼ .647). The median value of SUVmax for c-stage I/p-stage II-IV was significantly greater than that for c-stage I/p-stage I (6.6 vs. 2.2; P < .001).
Discussion
In the present study, all dynamic contrast-enhanced MDCT scans were performed at < 1 mm of slice thickness to minimize the measuring error due to the partial volume effect, especially in smallsize tumors, and to improve recognition of pleural, chest wall, and mediastinal involvement. The early phase of dynamic scans increases the contrast enhancement between pulmonary vessels and soft tissue, enhancing the ease of detecting hilar lymph node swelling. In contrast, the delayed phase decreases the amount of artifacts due to the dense contrast material in the subclavian vein and superior vena cava. In many cases, FDG PET/CT was also performed to check for primary and metastatic lesions.
The accuracy of the c-stage is relatively low, at about 50% to 60%, even if FDG PET/CT is routinely used during the 10 In their subanalysis of c-stage I patients, the concordance rate between cstage and p-stage was 59.9%, and 22.6% were upstaged to p-stage II-III. 9 In our study, the concordance rate between c-stage and pstage was 65.1%, and 9.4% of c-stage I patients were upstaged to pstage II-IV. The accuracy in the present study was slightly better than that in the Dutch Lung Surgery Audit study, probably because we used standard MDCT and PET/CT scanning protocols at a single institution. We investigated further whether the concordance between the c-stage and p-stage was associated with the postoperative prognosis. Among the c-stage I and p-stage I tumors, the discordance in staging was not significantly associated with the postoperative prognosis. The discordance between c-stage IA and p-stage IB and between c-stage IB and p-stage IA resulted from differences in the evaluation of tumor size and pleural invasion. The variation between c-stage and IA  IB  IIA  IIB  IIIA  IIIB  IV   IA  142  38  5  1  1  0  0  IB  24  36  2  1  0  0  0  IIA  2  5  7  0  0  0  0  IIB  3  2  0  0  0  0  0  IIIA  3  8  1  0  3  0  1  IIIB  0  0  1  0  0  0  0  I V  0  2  0  0  0  0  1 p-stage could also be affected by tumor shrinkage on formalin-fixed specimens; this was supported by our finding that the difference between the c-size and p-size was not significant for solid nodules but was for GGNs. Also, errors in measurement and the interval between the MDCT scan and surgery could have influenced our results. Currently, the preoperative diagnosis of pleural invasion is greatly limited. At our institution, extensive contact between a solid tumor and pleura and the presence of severe pleural indentations are considered pleural invasion. The size and SUVmax of the primary lesion were also considered in the evaluation of pleural invasion. Upstaging from c-stage I to p-stage II-IV was significantly associated with a poor prognosis. The main reasons for this discordance were underestimation of lymph node metastasis, chest wall invasion, and pleural dissemination. Nodal upstaging after surgery for both c-stage I NSCLC and small-cell lung cancer occurs when unsuspected lymph node metastases are found during the final histopathologic evaluation of surgical specimens. 15, 16 Lymph nodes are typically considered positive when the short-axis diameter on MDCT is > 10 mm or when the FDG uptake on PET/CT exceeds a visually large vascular space in the mediastinum. However, micrometastases might be present in lymph nodes < 10 mm. In such cases, FDG uptake is usually low because of the limited spatial resolution of PET/CT. Recently, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal lymph nodes has become a routine minimally invasive modality for nodal staging, with 69% to 95% sensitivity for NSCLC. 17 However, even if EBUS-TBNA is available, it is not usually feasible to sample all mediastinal and hilar lymph nodes preoperatively. Chest wall invasion can occur even in small-size lung cancer. Approximately 40% to 50% of patients with chest wall invasion have thoracic pain, although local pain is not always a sensitive indicator of chest wall invasion. 18 Rib destruction on the CT scan is a reliable sign of chest wall invasion. 19, 20 However, the patients in the present study had no chest pain and no rib destruction was seen on MDCT. Pleural dissemination often coexists with malignant pleural effusion; however, unexpected dry pleural dissemination is occasionally identified during surgery. 21 In our cohort, all 4 p-stage IV tumors had pleural dissemination without effusion, which appeared in 1 case as miliary nodules on the pleura on preoperative MDCT. Two c-stage IV patients demonstrated miliary nodules on the pleura, which were thought to be pleural dissemination on the preoperative MDCT. After thoracic surgery, 1 patient had pleural dissemination without effusion, but another patient had no pleural dissemination. Using the Kaplan-Meier method, the DFS curve of c-stage II-IV/ p-stage I showed a nonsignificant worse prognosis than that of c-stage I/p-stage I. The main reason for downstaging could have been an overestimation of hilar lymph node metastases. Even if malignancy could not be proved pathologically on the dissected lymph nodes, micrometastasis could have been latent in the lymph nodes with reactive swelling. Survival was reported to be significantly better when more lymph nodes were dissected. 22 Examining more lymph nodes might eliminate micrometastasis, increasing the likelihood of accurate staging and influencing survival. Alternatively, radiologists might regard hilar lymph node swelling as metastasis because of high FDG uptake in the primary lesion. However, bilaterally symmetric swelling and FDG uptake of hilar and mediastinal lymph nodes are generally considered reactive lymphadenopathy. Patients with lymphadenopathy should be carefully monitored after surgery, even if metastasis was not proved pathologically.
On univariate analysis, age, a solid nodule, SUVmax, nonadenocarcinoma histologic type, c-stage, p-stage, and discordance between the c-stage and p-stage were significant postoperative prognostic factors. Discordance between the c-stage and p-stage, especially between c-stage I and p-stage II-IV, correlated significantly with postoperative recurrence. The surgical procedure was not a significant factor, probably because the patient selection for limited surgery, which increases the potential for local recurrence, was appropriate at our institution. On multivariate analysis, only p-stage and SUVmax, but not c-stage, were significant prognostic indicators of DFS. The reason that c-stage was not a significant indicator of prognosis was probably the relatively small number of c-stage II-IV patients in our cohort, because c-stage IIIB and IV lung cancer cases are usually not indicated for surgery. Therefore, our results do not indicate that c-stage is insignificant. In addition, a combination of c-stage and SUVmax of the primary tumor was a significant prognostic indicator of DFS. Thus, SUVmax ! 2.5 and c-stage I patients had a significantly poorer prognosis than SUVmax < 2.5 and c-stage I patients. Although the SUVmax was not adopted as a criterion for c-stage in the latest TNM classification (8th edition of Union for International Cancer Control) or as an independent predictive indicator in p-stage, [23] [24] [25] a combination of c-stage and SUVmax might predict the postoperative prognosis more accurately. Conventionally, the c-stage was used to determine the treatment strategy for lung cancer, and the c-stage tended to be downstaged more often than the p-stage in doubtful cases. In general, surgical resection has been the first choice for c-stage I lung cancer; however, the use of SRT has been increasing in recent years as an alternative therapy. With SRT, an immune effect arising after radiotherapy in nonirradiated metastatic sites has been reported as an "abscopal effect." 26, 27 It shows the potential to clear micrometastases from the radiation field. However, the p-stage cannot be confirmed with SRT and the assessment is based only on the c-stage. The implications on the post-therapeutic prognosis by clinical upstaging of lymph nodes, chest wall invasion, and pleural dissemination status using MDCT and PET/CT should be remembered. In addition, the possibility of downstaging could affect a poor prognosis. The SUVmax, which was an independent prognostic factor from the p-stage, could aid in the preoperative or preradiation evaluation of the c-stage. The present retrospective, single-center study had several limitations. First, the sample size of the downstaged and upstaged tumors was relatively small, and the median postoperative follow-up period was relatively short at 47 months. Second, patients who had undergone preoperative PET/CT at other institutions did not undergo repeat PET/CT at our institution. The SUVmax depends on various factors, including the PET/CT scanner specifications and 
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Clinical Lung Cancer January 2018 -e43 reconstruction parameters. In the 20% of cases in our cohort, therefore, the SUVmax of the primary lesions was not used for analysis. However, in such cases, the PET/CT scans at other institutions were assessed visually to determine the c-stage. Third, no invasive mediastinal nodal staging was performed because EBUS-TBNA was rarely used until 2013 in our institution. Radiologic nodal staging is insufficient, and invasive nodal staging should be considered for cases of mediastinal lymph node metastasis suspected on PET/CT. 17, 28 Fourth, 3 of 289 tumors (1.0%) in our cohort were c-stage I small-cell lung cancers. With small-size tumors, confirmation of the preoperative pathologic diagnosis can be difficult. 29 Additionally, surgical resection for stage I small-cell lung cancer has been associated with significantly improved survival and should be considered in their management.
30,31

Conclusion
The concordance rate between the c-stage and p-stage of smallsize primary lung cancers was 65.4%, and an upstaging rate from c-stage I to p-stage II-IV was observed in 9.4%. Discordance between c-stage IA and p-stage IB did not correlate significantly with postoperative DFS. However, discordance between c-stage I and p-stage II-IV affected DFS significantly. In particular, nodal staging was not sufficient to support decisions on the optimal therapeutic strategy for these patients. The SUVmax of the primary lesion was an independent prognostic factor, and combining it with the c-stage might improve the prediction of therapeutic outcomes.
Clinical Practice Points
Good correlation between the c-stage and p-stage of small-size primary lung cancer is crucial; otherwise, the treatment outcomes would be difficult to compare between surgery and radiotherapy. Contrast-enhanced MDCT and FDG PET/CT is useful for determining the c-stage and therapeutic strategy, although recent studies have reported that the accuracy of c-stage is low. In the present study, concordance rate between the c-stage and p-stage for lung cancer 3 cm was 65.1%, and upstaging from c-stage I to p-stage II-IV was observed in 9.4%. Variations between c-stage I and p-stage II-IV resulted in a poor postoperative prognosis. Multivariate survival analysis showed that the p-stage and SUVmax of the primary lesion on PET/CT are independent prognostic factors. 
